NewGenIvf Group Limited 提交 6-K，披露已发行及流通 A 类普通股数量

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2026

Commission File Number: 001-42004

NEWGENIVF GROUP LIMITED

36/39-36/40, 13th Floor, PS Tower

Sukhumvit 21 Road (Asoke)

Khlong Toei Nuea Sub-district

Watthana District, Bangkok 10110 

Thailand

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒     Form 40-F ☐

EXPLANATORY NOTE

NewGenIVF Group Limited (the “Company”) confirms that as at the close of business on October 1, 2026, its total issued and outstanding class A ordinary shares (“Shares”) was 27,287,002 Shares, following share issuances in connection with the best efforts offering announced on September 30, 2026, the conversion of certain outstanding convertible promissory notes by certain convertible note holders, and shares issuances pursuant to the Company’s equity line of credit facility.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: October 5, 2026

2